Zobrazeno 1 - 2
of 2
pro vyhledávání: '"interim PET scans"'
Autor:
Abraham Avigdor, Fabrizio Trinchese, Francois Gavini, Nawal Bent‐Ennakhil, Mehul Dalal, Athanasios Zomas, Sharmeen Gettner Broun, Guido Gini
Publikováno v:
eJHaem, Vol 3, Iss 2, Pp 415-425 (2022)
Abstract Classical Hodgkin lymphoma (cHL) is curable in 90% of cases, but advanced stage patients who do not respond well to first‐line (1L) therapy have poorer outcomes. This retrospective study examines patient characteristics, treatment patterns
Externí odkaz:
https://doaj.org/article/d8aaca1bd51742e6a3075eac414b7e19
Autor:
Avigdor A; The Chaim Sheba Medical Center Institute of Hematology Ramat Gan Israel.; Sackler Faculty of Medicine Tel Aviv University Tel Aviv Israel., Trinchese F; Takeda Pharmaceuticals International AG Zurich Switzerland., Gavini F; Takeda Pharmaceuticals International AG Zurich Switzerland., Bent-Ennakhil N; Takeda Pharmaceuticals International AG Zurich Switzerland., Dalal M; Millennium Pharmaceuticals, Inc. A wholly owned subsidiary of Takeda Pharmaceutical Company Ltd Cambridge Massachusetts USA., Zomas A; Takeda Pharmaceuticals International AG Zurich Switzerland., Gettner Broun S; Kantar Paris France., Gini G; Ospedali Riuniti di Ancona Clinic of Hematology, Ancona, Italy.
Publikováno v:
EJHaem [EJHaem] 2022 Apr 19; Vol. 3 (2), pp. 415-425. Date of Electronic Publication: 2022 Apr 19 (Print Publication: 2022).